References
- Pallisgaard G, Tuberkulose-situationen i Gronland 1997. Nuna Med 1997; 10: 188–192. [In Danish].
- Soborg C, Soborg B, Poulsen S, Pallisgaard G,Thybo S, Bauer J. Doubling of the tuberculosis incidence in Greenland over an 8-year period (1990–1997). Int J Tuberc Lung Dis 2001; 5 (3): 257–265.
- TB Guideline, The Office of the Chief Medical Officer, Nuuk dated May 9th, 2000 [In Danish]
- Annual Report I 998, The Office of the Chief Medical Officer, Nuuk
- Annual Report I 1999, The Office of the Chief Medical Officer, Nuuk
- Annual Report 2000,The Office of the Chief Medical Officer, Nuuk
- Annual Report 2001, The Office of the Chief Medical Officer, Nuuk
- Annual Report 2002,The Office of the Chief Medical Officer, Nuuk
- Siddiqi SH. Bactec 460 TB System. Product and Procedure Manual. Sparks, MD: Becton Dickinson Microbiology Systems, 1996.
- van Embden JD, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31 (2): 406–409.
- Glynn JR Bauer J, de Boer AS et al. Interpreting DNAfingerprint clusters of Mycobacterium tuberculosis. European Concerted Action on Molecular Epidemiology and Control of Tuberculosis. Int J Tuberc Lung Dis 1999; 3 (12): 1055–60
- Enarson DA, Seita A, Fujiwara P. Global elimination of tuberculosis: Implementation, innovation, investigation. Int J Tuberc Lung Dis 2003; 7 (12): S328–S332.
- TB Outbreak report, The Office of the Chief Medical Officer, Nuuk dated March 11th 2002 [In Danish]
- WHO “Tuberculosis handbook” WHO/TB/98.253, 1998
- Rinder H, Mieskes KT, Loscher T. Heteroresistance inMycobacterium tuberculosis. Int J Tuberc Lung Dis 2001;5 (4): 339–45.
- WHO fact sheet #104. http://www.who.int/media centre/factsheets/whoI04/en/ [Accessed Jan 2nd, 2004]